BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naghizadeh S, Mohammadi A, Duijf PHG, Baradaran B, Safarzadeh E, Cho WC, Mansoori B. The role of miR-34 in cancer drug resistance. J Cell Physiol 2020;235:6424-40. [PMID: 32064620 DOI: 10.1002/jcp.29640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Z, Liu T, Ren X, Yang M, Tu C, Li Z. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks. Cell Cycle 2022;:1-11. [PMID: 35699451 DOI: 10.1080/15384101.2022.2087755] [Reference Citation Analysis]
2 Mengual D, Medrano LE, Villamizar-villamizar W, Osorio-llanes E, Mendoza-torres E, Bolívar S. Novel Effects of Statins on Cancer via Autophagy. Pharmaceuticals 2022;15:648. [DOI: 10.3390/ph15060648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li ZH, Zhou JH, Chen SN, Pan L, Feng Y, Luo MQ, Li RX, Sun GL. MicroRNA-506 has a suppressive effect on the tumorigenesis of nonsmall-cell lung cancer by regulating tubby-like protein 3. Bioengineered 2021;12:10176-86. [PMID: 34874810 DOI: 10.1080/21655979.2021.2001216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Vahabi M, Blandino G, Di Agostino S. MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies. Transl Cancer Res 2021;10:3090-110. [PMID: 35116619 DOI: 10.21037/tcr-20-2530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yu D, Xu Z, Cheng X, Qin J. The role of miRNAs in MDMX-p53 interplay. J Evid Based Med 2021;14:152-60. [PMID: 33988919 DOI: 10.1111/jebm.12428] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Raue R, Frank AC, Syed SN, Brüne B. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment. Int J Mol Sci 2021;22:2210. [PMID: 33672261 DOI: 10.3390/ijms22042210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li B, Liu J, Xin X, Zhang L, Zhou J, Xia C, Zhu W, Yu H. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int J Med Sci 2021;18:615-25. [PMID: 33437196 DOI: 10.7150/ijms.51589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Shchegolev Y, Sorokin D, Scherbakov A, Shunaev A, Andreeva O, Mikhaevich E, Gudkova M, Bure I, Berstein L, Nemtsova M, Krasil'nikov M. Upregulation of Akt/Raptor signaling is associated with rapamycin resistance of breast cancer cells. Chem Biol Interact 2020;330:109243. [PMID: 32861747 DOI: 10.1016/j.cbi.2020.109243] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Barth DA, Juracek J, Slaby O, Pichler M, Calin GA. lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System. Cancers (Basel) 2020;12:E2148. [PMID: 32756406 DOI: 10.3390/cancers12082148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]